Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-019899

CEO sold 3,621 shares at $6.53 ($23,638)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Shah Gaurav CEO 2025-05-16 Sale −3,621 $6.53 $23,638 789,059 D: show line 1 in the form
Open-market sales · 3,621 sh · avg $6.53 · $23,638
Loading xslF345X05/form4.xml…